SCENAR Therapy in Chronic Non-specific Neck Pain
Eligible age
18–80 yrs
Accepts
All genders
Locations
0 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Shifting away from a medication-centered approach is a major public health priority, particularly in chronic pain management, where non-pharmacological therapies are recommended despite barriers such as limited evidence and low prescriber awareness. SCENAR (Self-Controlled Energo-Neuro Adaptive Regulation), an electrotherapy device, lacks robust randomized controlled trial data. A prior study showed effects in both active and placebo groups after a single session, supporting further investigation. This study aims to assess whether repeated SCENAR sessions improve disability, mobility, and pain in patients with chronic neck pain.
Sponsor: Hopital Foch
You may qualify if…
- ✓ Male or female participants aged 18 years or older
- ✓ Patients with chronic non-specific cervical spine pain, including cervicobrachial neuralgia, persisting for at least 3 months, with no identifiable underlying cause requiring specific treatment.
- ✓ Patients who attended a pain clinic consultation or were referred to a pain specialist during hospitalization.
- ✓ Neck Disability Index (NDI) score of at least 30% (≥15 points).
- ✓ Written informed consent provided prior to study participation.
- ✓ Patient affiliated to a national health insurance
You may not qualify if…
- ✕ Pregnant women
- ✕ Skin conditions preventing SCENAR use (wounds, recent scars, skin infections)
- ✕ Initiation or change of analgesic treatment within 15 days prior to inclusion or during the study
- ✕ Cervical pain related to inflammatory (spondyloarthropathy, rheumatoid arthritis, chondrocalcinosis), traumatic (fractures, dislocations), tumor-related (metastases, myeloma), infectious (spondylodiscitis), or neurological (intramedullary or posterior fossa tumor) causes
- ✕ Previous SCENAR or ECOMODYN session
- ✕ Implanted pacemaker or defibrillator
- ✕ Inability to understand French
- ✕ Adults under legal protection
Source: ClinicalTrials.gov · NCT07742228 · last updated 2026-08-03